Syndax Pharmaceuticals (SNDX) PT Raised to $34 at Goldman Sachs
Goldman Sachs analyst Corinne Johnson ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
